These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1468429)

  • 1. Pharmacokinetics of loracarbef and interaction with acetylcysteine.
    Roller S; Lode H; Stelzer I; Deppermann KM; Boeckh M; Koeppe P
    Eur J Clin Microbiol Infect Dis; 1992 Sep; 11(9):851-5. PubMed ID: 1468429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic profile of loracarbef.
    DeSante KA; Zeckel ML
    Am J Med; 1992 Jun; 92(6A):16S-19S. PubMed ID: 1621740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of new oral cephalosporins, including a new carbacephem.
    Fassbender M; Lode H; Schaberg T; Borner K; Koeppe P
    Clin Infect Dis; 1993 May; 16(5):646-53. PubMed ID: 8507756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic disposition of loracarbef in healthy young men and women at steady state.
    Sitar DS; Hoban DJ; Aoki FY
    J Clin Pharmacol; 1994 Sep; 34(9):924-9. PubMed ID: 7983236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of the new oral cephalosporins.
    Lode H; Fassbender M; Schaberg T; Borner K; Koeppe P
    Drugs; 1994; 47 Suppl 3():10-9; discussion 19-20. PubMed ID: 7518762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of loracarbef in pediatric patients.
    Nahata MC; Koranyi KI
    Eur J Drug Metab Pharmacokinet; 1992; 17(3):201-4. PubMed ID: 1490489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics, tissue penetration and in-vitro activity of loracarbef, a beta-lactam antibiotic of the carbacephem class.
    Lees AS; Andrews JM; Wise R
    J Antimicrob Chemother; 1993 Dec; 32(6):853-9. PubMed ID: 8144425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loracarbef: a new orally administered carbacephem antibiotic.
    Force RW; Nahata MC
    Ann Pharmacother; 1993 Mar; 27(3):321-9. PubMed ID: 8453172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of four different types of diet on the bioavailability of loracarbef.
    Bapujee AT; Singh T; Ahmed T; Monif T; Saha N; Sharma PL
    Eur J Drug Metab Pharmacokinet; 2007; 32(4):205-11. PubMed ID: 18348469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of loracarbef on the normal oropharyngeal and intestinal microflora.
    Nord CE; Grahnen A; Eckernäs SA
    Scand J Infect Dis; 1991; 23(2):255-60. PubMed ID: 1853174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of renal dysfunction on the pharmacokinetics of loracarbef.
    Therasse DG; Farlow DS; Davidson RL; Quadracci LJ; Hatcher BL; Cerimele BJ; DeSante KA
    Clin Pharmacol Ther; 1993 Sep; 54(3):311-6. PubMed ID: 8375126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefetamet pivoxil and interaction with cisapride and N-acetylcysteine.
    Gutleben KJ; Eller J; Vöckler J; Rau M; Koeppe P; Kotwas J; Lode H
    Clin Microbiol Infect; 1997 Apr; 3(2):170-174. PubMed ID: 11864100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic determination of loracarbef, a potential metabolite, cefaclor and cephalexin in human plasma, serum and urine.
    Kovach PM; Lantz RJ; Brier G
    J Chromatogr; 1991 Jun; 567(1):129-39. PubMed ID: 1918240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis.
    Hyslop DL; Bischoff W
    Am J Med; 1992 Jun; 92(6A):86S-94S. PubMed ID: 1621752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sputum and serum pharmacokinetics of loracarbef (LY163892) in patients with chronic bronchial sepsis.
    Hill SL; Bilton D; Johnson MM; Pye A; Mitchell JL; Stockley RA
    J Antimicrob Chemother; 1994 Jan; 33(1):129-36. PubMed ID: 8157553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety profile of loracarbef: clinical trials in respiratory, skin, and urinary tract infections.
    Therasse DG
    Am J Med; 1992 Jun; 92(6A):20S-25S. PubMed ID: 1621742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of loracarbef into the maxillary sinus: a pharmacokinetic assessment.
    Stenquist M; Olen L; Jannert M; Näslund L; Zeckel ML
    Clin Ther; 1996; 18(2):273-84. PubMed ID: 8733988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of N-acetylcysteine in man.
    Borgström L; Kågedal B; Paulsen O
    Eur J Clin Pharmacol; 1986; 31(2):217-22. PubMed ID: 3803419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefpiramide in healthy volunteers, patients with various degrees of renal dysfunction, and patients on hemodialysis.
    Ohkawa M; Tokunaga S; Sugata T; Shimamura M; Okasho A; Hirano S; Matsui H
    Chemotherapy; 1989; 35(6):416-22. PubMed ID: 2612231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I clinical trial of cefditoren pivoxil (ME 1207): pharmacokinetics in healthy volunteers.
    Li JT; Hou F; Lu H; Li TY; Li H
    Drugs Exp Clin Res; 1997; 23(5-6):145-50. PubMed ID: 9515223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.